Canada Markets close in 6 hrs 10 mins

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
29.03-0.02 (-0.07%)
As of 9:48AM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 51.08B
Enterprise Value 3825.47M
Trailing P/E N/A
Forward P/E 1-12.62
PEG Ratio (5 yr expected) 1-5.05
Price/Sales (ttm)17.86
Price/Book (mrq)2.72
Enterprise Value/Revenue 313.60
Enterprise Value/EBITDA 6-5.58

Trading Information

Stock Price History

Beta (5Y Monthly) 0.94
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 354.97
52 Week Low 320.03
50-Day Moving Average 328.24
200-Day Moving Average 334.29

Share Statistics

Avg Vol (3 month) 3346.01k
Avg Vol (10 day) 3376.85k
Shares Outstanding 537.33M
Float 27.35M
% Held by Insiders 114.83%
% Held by Institutions 192.37%
Shares Short (Sep. 29, 2020) 44.34M
Short Ratio (Sep. 29, 2020) 410.89
Short % of Float (Sep. 29, 2020) 418.45%
Short % of Shares Outstanding (Sep. 29, 2020) 411.63%
Shares Short (prior month Aug. 30, 2020) 44.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin -222.24%
Operating Margin (ttm)-256.69%

Management Effectiveness

Return on Assets (ttm)-19.89%
Return on Equity (ttm)-30.22%

Income Statement

Revenue (ttm)60.68M
Revenue Per Share (ttm)1.64
Quarterly Revenue Growth (yoy)110.20%
Gross Profit (ttm)-97.19M
EBITDA -147.84M
Net Income Avi to Common (ttm)-134.85M
Diluted EPS (ttm)-3.64
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)269.19M
Total Cash Per Share (mrq)7.21
Total Debt (mrq)10.1M
Total Debt/Equity (mrq)2.54
Current Ratio (mrq)8.19
Book Value Per Share (mrq)10.67

Cash Flow Statement

Operating Cash Flow (ttm)-111.73M
Levered Free Cash Flow (ttm)-97.77M